Mehrdad Pourfathi1, Hooman Hamedani1, Yi Xin1, Stephen Kadlecek1, Maurizio Cereda2, Harrilla Profka1, Ian Duncan1, Nicholas Drachman1, Sarmad Siddiqui1, Kai Ruppert1, Joe Naji1, and Rahim Rizi1
1Radiology, University of Pennsylvania, Philadelphia, PA, United States, 2Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia, PA, United States
Synopsis
In this hyperpolarized pyruvate imaging study of acute lung injury, we assessed alterations of regional lactate-to-pyruvate ratio during the progression of lung inflammation caused by acid aspiration. The study shows that posterior lactate-to-pyruvate ratio changes more significantly after injury compared to the anterior ratio. This is consistent with the pattern observed with proton MRI. We report good correlation between increased lactate-to-pyruvate ratio due to inflammation and increased proton image intensity as a result of formation of edema, especially in the posterior regions.
Introduction
Several
imaging modalities have been used to examine structural and functional changes
to the lung after acute injury [1-2].
While
these approaches are very useful, they examine the secondary effects of inflammation rather than targeting the
underlying changes in cellularity. Recently, hyperpolarized pyruvate has shown
great promise for studying the underlying alterations in metabolism and pH caused
by acute lung inflammation [3-5]. However, no studies have assessed the spatial
heterogeneity of metabolic alterations in the presence of global acute lung
injury. We hypothesize that assessment of regional information can provide better
insight into patient care and management of acute inflammation. In this study,
we demonstrate that hyperpolarized pyruvate imaging can be used to assess
regional changes of metabolism during the progression of experimental acid
aspiration lung injury. Methods
Eighteen
Sprague-Dawley rats (335±34g) were ventilated with a tidal volume (TV) of 7.9±0.7
mL/kg and a positive end-expiratory pressure (PEEP) of 7.1±2.1cmH2O
for 5hrs. Injured rats received doses of HP [1-13C]-pyruvate at
t=60min, t=120 and t=300min after the start of ventilation. Hydrochloric acid
(pH 1.25) was instilled into the trachea of the rats at t=70min at varying
dosages (0.5ml/kg (n=2), 1ml/kg(n=11) and 2ml/kg (n=5)) to achieve different severity
of injury between cohorts. Dynamic pulmonary compliance was measured by
dividing peak-inspiratory pressure (PIP) by TV in the absence of PEEP [1], and
blood oxygen level was monitored using a pulse oximeter. All rats were imaged
in the supine position using a 1H/13C quadrature birdcage
coil (m2m) at 4.7T (Varian Inc.). Proton images were acquired using a multi-slice
gradient echo (TR/TE=80/1.5ms, α=10°, 128x128 voxels). ~22 µL of [1-13C]-pyruvate
was polarized using a HyperSense DNP polarizer (Oxford Instruments) for over 1hr
and was subsequently melted using 4mL of a dissolution buffer (40mM Trizma,
160mM NaOH, 50mM NaCl, 0.1g/L EDTA) at 180°C to yield a neutral isotonic
solution of 80mM [1-13C]-pyruvate at ~37°C. 12s after the
dissolution, hyperpolarized pyruvate was administered via the tail-vein within
8s at 5.7±2.0ml/kg dose. An axial carbon-13 chemical shift image was acquired 12s
after the end of injection using a 16x16 FID-CSI sequence (TR/TE=35/0.35ms,
α=12°, FOV=45x45mm2, 15mm slice thickness) with a custom outward
spiral k-space trajectory [7]. Respiratory motion was mitigated during carbon
imaging by applying a 12s breath-hold. Metabolic maps were generated and voxels
covering the lungs and the corresponding areas in the proton images were
manually segmented into four regions (anterior, posterior, left and right:
shown in figure 1) using custom-made
routines in MATLAB2014b. All data were exported to R for statistical
analysis. Results and Discussion
Figure 2 shows the average of the lactate-to-pyruvate
ratio in the four regions of the lung as a function of injection number,
demonstrating that the lactate-to-pyruvate ratio changes similarly in the left
and right sides of the lung for all injections. In the posterior regions, however,
the lactate-to-pyruvate ratio increases more significantly than in the anterior
areas. This is consistent with the pattern of edema formation and its progression
as observed with proton MRI (figure 3) and CT [1] for this injury model. The Increased
lactate-to-pyruvate ratio is a result of the infiltration of neutrophils into
the lungs upon injury [4-5]. It is important to note that blurring associated
with cardiac motion in voxels near the heart can affect accurate quantification
of the metabolites in the anterior regions of the lungs. Comparisons between
the regional lactate-to-pyruvate ratio and the normalized proton signal intensity for all
injured cohorts (figure 4) show a similar trend, and there appears to be a good
correlation between the lactate-to-pyruvate ratio and proton signal intensity in
injured-0.5 and injured-1 cohorts in the posterior regions. In the case of severe
injury (injured-2) no obvious correlation is observed between the carbon and
proton images. This is possibly due to dramatically increased blood flow in
very severe cases of injury [6], which may lower the lactate-to-pyruvate ratio
as the injury progresses [8]. Conclusions
Regional analysis shows that the lactate-to-pyruvate ratio in injured
lungs alters more significantly in the posterior regions than in the anterior
regions. This suggests that regional lactate-to-pyruvate ratio may be a more
sensitive biomarker for pulmonary inflammation, as it can show alterations that
are otherwise masked by the preponderance of healthy lung in the global lactate-to-pyruvate
ratio. This study shows that the development of pulse sequences capable of
providing high resolution maps of pulmonary metabolism can improve the sensitivity
of hyperpolarized carbon-13 as a tool to characterize lung inflammation.Acknowledgements
This work was
supported by the National of Institutes of Health (NIH) R01 HL124986.References
[1] Cereda M. et al, Anesthesiology, 2016;124:121–131
[2] Mistry N. et al, MRM, 2008;59:289–297
[3] Drachman N. et al, MRM Sep 2016,
[4] Thind K. et al, Radiotherapy and Oncology 2014;110:317–322
[5] Shaghaghi
et. al., NMR in biomedicine, 27(8):939-947 (2014).
[6] KENNEDY TP, et al. anesth.
Analg. 1989;69:87–92.
[7] Kadlececk S, et al. The 24th Annual Meeting of ISMRM
2016.
[8] Pourfathi M. et al, American Thoracic Society,
May 2016, San Francisco, CA.